GlobeNewswire

Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
12/08/2026
Milestone strengthens manufacturing flexibility and supports pivotal study readiness BURLINGTON, Mass, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, [...]
Reflect Scientific Reports More Than $1.4 Million in Freezer-System Sales to Biopharmaceutical Customers
12/08/2026
OREM, Utah, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF) today announced more than $1.4 million in delivered commercial freezer-system sales to six biopharmaceutical companies during the [...]
Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors
12/08/2026
CONSHOHOCKEN, Pa., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
ADARx Pharmaceuticals Expands Leadership Team with Board and Executive Appointments
12/08/2026
– Ying Huang, Ph.D. appointed to Board of Directors, bringing deep experience spanning executive public biotech leadership, Wall Street and big pharma R&D – – Robert Ackles joins as Chief People Officer, bringing [...]
Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates
12/08/2026
Received FDA clearance of IND application for XTX501, a potential best-in-class bispecific PD-1 / masked IL-2 Advancing IND-enabling studies for potential first-in-class multi-specific, masked T cell engager programs [...]
BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights
12/08/2026
Record s econd q uarter 2026 r evenue increased 35% t o $17. 1 m illion, compared with Q2 2025 Adjusted EBITDA more than doubled year-over-year to $3.5 million, with margin expanding to 20% Remaining performance [...]
PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results
12/08/2026
FDA Accepted D-PLEX₁₀₀ NDA with Priority Review; PDUFA Goal Date of November 28, 2026, Approximately One Quarter Ahead of Previously Communicated Guidance Exclusive U.S. and Canada Commercialization Partnership with [...]
Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates
12/08/2026
Randomized Phase 2 trial in microsatellite stable colorectal cancer (MSS CRC) ongoing, with results expected in 1H 2027; potential registration trial expected in 2027 once recommended dose regimen has been established [...]
Altimmune Announces Second Quarter 2026 Financial Results and Business Update
12/08/2026
Initiated global PERFORMA Phase 3 trial in MASH Reported positive topline data from RECLAIM Phase 2 trial in AUD Completed patient enrollment in RESTORE Phase 2 trial in ALD $519 million in cash, cash equivalents and [...]
Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update
12/08/2026
Maintained strong financial position with cash, cash equivalents and marketable securities of $92.6M as of June 30, 2026 Received first payment of approximately $178M from Moderna settlement in July and expects to [...]
Novonesis launches Optiva® Triticum to help pasta manufacturers navigate wheat volatility without compromising quality
12/08/2026
COPENHAGEN, Denmark, August 12, 2026 – Novonesis today announced the launch of Optiva® Triticum, a new biosolution that helps pasta manufacturers increase flexibility in wheat sourcing while maintaining the texture, [...]
Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
12/08/2026
Over 50% of commercially insured lives in the U.S., representing a recent and significant increase, now have coverage for CARDAMYST ® (etripamil) nasal spray Phase 3 registrational trial of etripamil for atrial [...]
Inc. Recognizes U.S. Oral Surgery Management as One of the Fastest-Growing Private Companies in America
12/08/2026
USOSM Earns a Place on the Inc. 5000 List for Revenue Growth IRVING, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- For the second year in a row, U.S. Oral Surgery Management ( USOSM ) has been named to the Inc. 5000 list, an [...]
Targeting The Mutant: NTHI’s NEO100 Data Could Open a New Front in the Fight Against Brain Cancer
12/08/2026
DALLAS, Aug. 12, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings (NASDAQ: NTHI) has delivered the kind of clinical update that can change the conversation around a small biotechnology company: its Phase 2a study of [...]
Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
12/08/2026
WILMETTE, Ill., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with [...]
Conavi Medical Corp. Announces Closing of $10M Public Offering
12/08/2026
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“ Conavi ” or the “ Company ”), a commercial stage [...]
Kyowa Kirin Introduces Family Outreach Initiative to Support Families Living with XLH
12/08/2026
New resources and events help guide meaningful conversations about the hereditary nature of XLH PRINCETON, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd., [...]
Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging
12/08/2026
Commercial initiative aims to make VMS+ easier for hospitals to evaluate and adopt TORONTO, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”) (TSXV: VPT; OTC: VPTDF), a [...]
LiveWorld Reports Second Quarter 2026 Financial Results
12/08/2026
LiveWorld continues to Increase its AI investment CAMPBELL, Calif. and NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), today announced financial results for second quarter 2026. Three [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum